280 related articles for article (PubMed ID: 32009093)
1. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.
Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093
[TBL] [Abstract][Full Text] [Related]
2. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y
Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer.
Okawa S; Kayatani H; Fujiwara K; Ozeki T; Takada K; Iwamoto Y; Minami D; Sato K; Shibayama T
Intern Med; 2019; 58(5):699-702. PubMed ID: 30828042
[TBL] [Abstract][Full Text] [Related]
4. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
Sugano T; Seike M; Funasaka Y; Yoshida M; Takayama R; Okamura K; Nakanishi A; Tanaka T; Takeuchi S; Noro R; Minegishi Y; Kubota K; Saeki H; Gemma A
J Immunother Cancer; 2019 Feb; 7(1):59. PubMed ID: 30813943
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
Zhai C; Jin X; You L; Yan N; Dong J; Qiao S; Zhong Y; Zheng Y; Pan H
BMC Geriatr; 2024 Jan; 24(1):32. PubMed ID: 38191289
[TBL] [Abstract][Full Text] [Related]
6. Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma.
Kobak S
Curr Drug Saf; 2019; 14(3):225-229. PubMed ID: 31132977
[TBL] [Abstract][Full Text] [Related]
7. Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature.
Rubio-Perez J; Rodríguez-Perez ÁR; Díaz-Blázquez M; Moreno-García V; Dómine-Gómez M
J Med Case Rep; 2022 Oct; 16(1):365. PubMed ID: 36195892
[TBL] [Abstract][Full Text] [Related]
8. Haemophagocytic lymphohistiocytosis complicating pembrolizumab treatment for metastatic breast cancer in a patient with the
Al-Samkari H; Snyder GD; Nikiforow S; Tolaney SM; Freedman RA; Losman JA
J Med Genet; 2019 Jan; 56(1):39-42. PubMed ID: 30287596
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Sadaat M; Jang S
J Immunother Cancer; 2018 Jun; 6(1):49. PubMed ID: 29871698
[TBL] [Abstract][Full Text] [Related]
10. Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
Kurokawa K; Hara M; Iwakami SI; Genda T; Iwakami N; Miyashita Y; Fujioka M; Sasaki S; Takahashi K
Intern Med; 2019; 58(22):3283-3287. PubMed ID: 31735738
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis.
Wang C; Sun W; Li Z; Wu T; Fang W
Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death protein 1 inhibitor-induced recalcitrant mixed small and medium vessel vasculitis.
Kullberg SA; Krug H; Gaddis K; Goldfarb N
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054944
[TBL] [Abstract][Full Text] [Related]
13. Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.
Kato M; Mori M; Miura K; Asao T; Motomura H; Nishino K; Ko R; Koyama R; Hayashi T; Takahashi K
Thorac Cancer; 2021 Nov; 12(22):3076-3079. PubMed ID: 34617405
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.
Hagiwara S; Tanizaki J; Hayashi H; Komeda Y; Nishida N; Yoshida A; Yamamoto T; Matsubara T; Kudo M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1960. PubMed ID: 38196303
[TBL] [Abstract][Full Text] [Related]
15. Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report.
Sackstein P; Zaemes J; Kim C
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330765
[TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab-Induced Rhabdomyolysis With Myositis in a Patient With Lung Adenocarcinoma.
Hamada S; Fuseya Y; Tsukino M
Arch Bronconeumol (Engl Ed); 2018 Jun; 54(6):346-348. PubMed ID: 29496287
[No Abstract] [Full Text] [Related]
17. Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab.
Alberti A; Mancin M; Cortinovis D; Bidoli P; Sala L
Immunotherapy; 2020 Jun; 12(9):629-633. PubMed ID: 32418466
[No Abstract] [Full Text] [Related]
18. Hemophagocytic lymphohistiocytosis in a rheumatoid arthritis patient treated with infliximab.
Oda Y; Urushidani Y; Ooi S; Endoh A; Nakamura R; Adachi K; Fukushima H
Intern Med; 2012; 51(6):655-7. PubMed ID: 22449679
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.
Ninomiya R; Kinehara Y; Tobita S; Konaka H; Jokoji R; Shintani T; Tachibana I
Intern Med; 2022 Aug; 61(15):2339-2341. PubMed ID: 35022350
[TBL] [Abstract][Full Text] [Related]
20. Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature.
Harada K; Ogasawara M; Shido A; Meno A; Oda S; Yoshida S; Yoshida S; Yoshikawa A; Ebata K; Abiko S; Kawagishi N; Sano I; Oda H; Miyagishima T
Thorac Cancer; 2020 May; 11(5):1350-1353. PubMed ID: 32181993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
